Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clinically Relevant Drug Product Specifications: Methods of Establishment

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...

Drug Regulation

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

Drug Product Stability

Drug Product Stability

The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...

Drug Products: Biologics, Biosimilars and Interchangeables

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Beyond standard therapy: clinical transdiagnostic study evaluating mindfulness-based training as an adjunct to CBT for dissociation.

Frontiers in psychiatry·2026

Same author

Primary and secondary metastatic dissemination: multiple routes to cancer-related death.

Molecular cancer·2025

Same author

Treatment outcome of NSCLC patients with BRAF<sup>non-V600E</sup> mutations: a retrospective, multicentre analysis within the national Network Genomic Medicine (nNGM) Lung Cancer in Germany.

ESMO open·2025

Same author

MR dacryocystography - Optimising a dynamic imaging protocol for patients with epiphora.

Radiography (London, England : 1995)·2024

Same author

Water-film thickness imaging based on time-multiplexed near-infrared absorption with up to 500 Hz repetition rate.

Applied optics·2023

Same author

[Helicobacter pylori eradication for prevention of ulcer bleeding].

Innere Medizin (Heidelberg, Germany)·2023

Search research articles

Related Experiment Video

Updated: Jun 13, 2026

Eye Irritation Test (EIT) for Hazard Identification of Eye Irritating Chemicals using Reconstructed Human Cornea-like Epithelial (RhCE) Tissue Model

Eye Irritation Test (EIT) for Hazard Identification of Eye Irritating Chemicals using Reconstructed Human Cornea-like Epithelial (RhCE) Tissue Model

Published on: August 23, 2015

[Cosmetic products : Safety aspects].

T Platzek¹, R Krätke, C Schulz

¹Bundesinstitut für Risikobewertung, Berlin. thomas.platzek@bfr.bund.de

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz

|May 14, 2010

Summary

This summary is machine-generated.

Manufacturers ensure cosmetic product safety through regulations and ingredient restrictions. Future assessments will adapt to the animal testing ban, maintaining consumer protection while enabling innovation.

Related Experiment Videos

Last Updated: Jun 13, 2026

Eye Irritation Test (EIT) for Hazard Identification of Eye Irritating Chemicals using Reconstructed Human Cornea-like Epithelial (RhCE) Tissue Model

Eye Irritation Test (EIT) for Hazard Identification of Eye Irritating Chemicals using Reconstructed Human Cornea-like Epithelial (RhCE) Tissue Model

Published on: August 23, 2015

Area of Science:

Cosmetic Science
Regulatory Affairs
Toxicology

Context:

Cosmetic product safety is primarily the manufacturer's responsibility.
Regulatory frameworks, including bans and restrictions on hazardous ingredients, are in place.
The European Union (EU) regulation on cosmetic products will be directly applicable across all member states.

Purpose:

To outline the current safety assurance mechanisms for cosmetic products.
To discuss impending changes in cosmetic ingredient safety assessment, particularly the ban on animal experiments.
To highlight the need to maintain high consumer protection standards alongside innovation.

Summary:

The safety of cosmetic products relies on manufacturer responsibility and regulatory controls, including ingredient bans and restrictions.
Future safety assessments will evolve due to the prohibition of animal testing, necessitating new methodologies.
The new EU regulation aims for direct applicability, ensuring consistent safety standards across member states.

Impact:

Ensures continued high consumer protection in the EU cosmetic market.
Facilitates innovation in cosmetic products without introducing unacceptable consumer risks.
Provides a framework for risk assessment of cosmetic ingredients, exemplified by diethylene glycol and boric acid.